Advanced glycation end-products: a review

2001/02/05 by Ravinder Singh, R. Singh, Anne Barden +5 · 32 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Advanced Glycation End Products research #Natural Antidiabetic Agents Studies #Neurological Disease Mechanisms and Treatments

paper · pdf · doi:10.1007/s001250051591

Cited by

• Effects of Buffer Composition on Site-Specific Glycation of Lysine Residues in Monoclonal Antibodies
• Fewer Exposed Lysine Residues May Explain Relative Resistance of Chicken Serum Albumin to In Vitro Protein Glycation in Comparison to Bovine Serum Albumin
• The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen–glucose deprivation
• New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
• The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
• Advanced glycation end products and human diseases
• Glycoxidation of biological macromolecules: A critical approach to halt the menace of glycation
• Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. [europepmc]
• Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. [europepmc]
• How does diabetes accelerate Alzheimer disease pathology? [europepmc]
• Review: Glycation of human serum albumin. [europepmc]
• Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. [europepmc]
• Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. [europepmc]
• Uremic Toxicity of Advanced Glycation End Products in CKD. [europepmc]
• The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification. [europepmc]
• Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages. [europepmc]
• Activation of Nrf2 signaling by natural products-can it alleviate diabetes? [europepmc]
• The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. [europepmc]
• Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology. [europepmc]
• Evaluating All Potential Oral Complications of Diabetes Mellitus. [europepmc]
• Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. [europepmc]
• Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. [europepmc]
• Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease. [europepmc]
• Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases. [europepmc]
• Why does COVID-19 disproportionately affect older people? [europepmc]
• High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. [europepmc]
• Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease. [europepmc]
• Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. [europepmc]
• Insulin and Insulin Resistance in Alzheimer's Disease. [europepmc]
• Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. [europepmc]
• Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs. [europepmc]
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. [europepmc]